General derivation of the ideal intravenous drug input required to achieve and maintain a constant plasma drug concentration. Theoretical application to lignocaine therapy
- 1 January 1976
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 10 (6), 433-440
- https://doi.org/10.1007/bf00563080
Abstract
A constant plasma drug concentration can be achieved and maintained by the intravenous administration of an initial bolus loading dose in conjunction with a constant rate and an exponential intravenous drug infusion. The drug input required to achieve a constant plasma drug concentration is derived without making any assumptions about the nature of drug distribution within the body or elimination from the body.This publication has 22 references indexed in Scilit:
- Logical approach to lignocaine therapy.BMJ, 1976
- Estimation of biological availability after oral drug administration when the drug is eliminated by urinary excretion and metabolismJournal of Pharmacy and Pharmacology, 1975
- TRIAL OF COMBINED INTRAMUSCULAR AND INTRAVENOUS LIGNOCAINE IN PROPHYLAXIS OF VENTRICULAR TACHYARRHYTHMIASThe Lancet, 1972
- ACUTE PHASE OF MYOCARDIAL INFARCTIONThe Lancet, 1971
- DISPOSITION KINETICS OF LIDOCAINE IN NORMAL SUBJECTS*Annals of the New York Academy of Sciences, 1971
- Intramuscular lidocaine in the therapy of ventricular arrhythmiasThe American Journal of Cardiology, 1971
- CONTROLLED TRIAL OF LIGNOCAINE IN PROPHYLAXIS OF VENTRICULAR ARRHYTHMIAS COMPLICATING MYOCARDIAL INFARCTIONThe Lancet, 1970
- Problems of the pre-hospital phase of acute myocardial infarctionThe American Journal of Cardiology, 1969
- LIGNOCAINE IN THE MANAGEMENT OF ARRHYTHMIAS AFTER ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1968
- A DYNAMIC CONCEPT OF THE DISTRIBUTION OF THIOPENTAL IN THE HUMAN BODYAnesthesiology, 1960